Skip to main content

Table 2 Risk factors associated with long term urinary toxicity (Univariate analysis)

From: Urinary function and quality of life after radiotherapy for prostate cancer in patients with prior history of surgical treatment for benign prostatic hyperplasia

 

IPSS ≤7

IPSS > 7

p

QOL < 3

QOL ≥3

p

CTCAE Grade < 2

CTCAE Grade ≥ 2

p

Initial prostate volume (g)

56

71

0.06

58

64

0.24

60

36

0.08

Resected prostate Volume (g)

28

24

0.3

26

30

0.2

27

16

0.1

CTV prostate (cc)

45

61

0.07

50

59

0.1

53

37

0.08

V70Gy (cc)

34

37

0.2

35

36

0.4

34

40

0.2

TURP-RT time interval (days)

312

398

0.2

312

382

0.2

306

614

0.05

Total dose of radiotherapy (Gy)

78.3

78.7

0,3

78

79.4

0.04

78.4

79

0.3

Hypertension

 No

24

3

0.5

21

6

0.04

27

0

0.05

 Yes

20

10

 

21

9

 

27

4

 

TURP indication

 Unknown

5

0

0.1

4

1

0.1

5

0

0.8

 Urinary symptoms

28

10

 

26

12

 

36

3

 

 Urinary retention

10

1

 

11

0

 

10

1

 

  High prostate volume

2

2

 

2

2

 

4

0

 

Androgen deprivation therapy

 No

23

9

0.2

25

6

0.2

29

3

0.3

 Yes

22

4

 

18

9

 

26

1

 
  1. IPSS International prostate symptom score, QOL urinary quality of life, CTCAE (Common Terminology Criteria for Adverse Events) version 4 grading system, TURP transurethral resection of the prostate
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us